Skip to main content

Table 1 Clinical features and laboratory findings of patients with NSIP

From: Prognosis of nonspecific interstitial pneumonia correlates with perivascular CD4+ T lymphocyte infiltration of the lung

  NSIP (n = 55)
Clinical manifestations, N (%)
Dyspnea 40 (72.7)
Cough 47(85.5)
Chest pain 4(7.3)
Dry eyes or dry mouth 3(5.5)
Fever 7 (12.7)
Arthralgia 9(16.4)
Skin rash 6(10.9)
Raynaud’s phenomenon 3(5.5)
Weight loss 4(7.3)
Crackles 41(74.6)
Clubbing 21(38.2)
Laboratory tests
 ESR, mm/h 21.2 ± 19.2
 PaO2, mmHg 77.8 ± 12.9
 PCO2, mmHg 37.9 ± 8.4
Serological results, N (%)
 Anti-nuclear antibody 14 (25.5)
 Anti-SSA antibody 3 (5.5)
 Anti-neutrophil cytoplasmic antibody 3 (5.5)
 Anti-Jo-1 antibody 1 (1.8)
 Anti-Scl-70 antibody 1 (1.8)
PFT
 TLC, % predicted 76.8 ± 14.1
 DLCO, % predicted 56.4 ± 16.8
Baseline chest CT findings, N (%)
 Ground glass opacity 34 (61.8)
 Patchy opacity 40 (72.7)
 Irregular reticular opacity 35 (63.6)
 Traction bronchiectasis 17 (30.9)
 Pleural thickness 5 (14.6)